Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online April 8, 2019.
Article Versions
- previous version (October 25, 2018 - 06:38).
- previous version (November 15, 2018 - 03:04).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2019
Author Information
- Paul W. Barone1,*,
- Stephen Avgerinos2,
- Rob Ballard3,
- Audrey Brussel4,
- Philip Clark5,
- Chris Dowd6,
- Lionel Gerentes7,
- Ian Hart8,
- Flora J. Keumurian1,
- Johanna Kindermann9,
- James C. Leung1,
- Nguyen Ly10,
- Sheldon Mink11,
- Stefan Minning12,
- Jürgen Mullberg13,
- Marie Murphy14,
- Kerstin Nöske15,
- Sandi Parriott16,
- Bonnie Shum5,
- Michael E. Wiebe1 and
- Stacy L. Springs1
- 1Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA, USA;
- 2Pfizer, Andover, MA, USA;
- 3Biogen, Durham, NC, USA;
- 4LFB, France;
- 5Amgen, Thousand Oaks, CA, USA;
- 6Genentech, South San Francisco, CA, USA;
- 7Sanofi, France;
- 8MedImmune, Gaithersburg, MD, USA;
- 9Shire, Vienna, Austria;
- 10Merck & Co., Inc., Kenilworth, NJ, USA;
- 11Regeneron, Rensselaer, NY, USA;
- 12Boehringer Ingelheim, Germany;
- 13Bristol-Myers Squibb, Devens, MA, USA;
- 14Eli Lilly, Dublin, Ireland;
- 15CSL Behring, Marburg, Germany; and
- 16BioMarin, San Rafael, CA, USA.
- ↵* Corresponding Author: Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; e-mail: pbarone{at}mit.edu
